Explore Business Standard
Don’t miss the latest developments in business and finance.
Germany will soon drop a mask mandate on long-distance trains and buses, one of the country's last remaining COVID-19 restrictions, the health minister said on Friday. The mandate will be dropped on February 2, Health Minister Karl Lauterbach announced in Berlin. Other European countries already have scrapped mask mandates in public transport, and Lauterbach faced increasing pressure to follow suit in recent weeks. Masks remain mandatory in doctors' practices, while masks and negative tests are still required to enter hospitals and nursing homes. Rules for local transportation are a matter for Germany's 16 state governments, and an increasing number have dropped or are dropping their mask mandates. Some also have scrapped rules requiring infected people to isolate at home. The long-distance transportation rules were scheduled to end on April 7, though legislation allows for them to be suspended earlier if the situation is better than expected. After one of Germany's top virologis
Zenara Pharma, a fully-owned subsidiary of the city-based Biophore India Pharmaceuticals, on Friday announced that it has launched generic Paxlovid (Nirmatrelvir and Ritonavir) tablets in a combi pack as a treatment option for patients with mild to moderate symptoms of Covid-19. A press release from the drug maker said Zenara Pharma has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market this product last month. The product, which will be sold under the brand name 'Paxzen,' is being manufactured at Zenara's US FDA and EU approved state-of-the-art facility in Hyderabad, it said. Pfizer's Paxlovid has been approved by US FDA for COVID treatment. The product will be sold at a Maximum Retail Price of Rs 5,200 per box, equivalent to one full course of treatment per patient, and contains 20 tablets of Nirmatrelvir 150ml and 10 Tablets of Ritonavir 100mg. Jagadeesh Babu Rangisetty, Co-founder and Managing Director at Zenara Pharma, s
Chhattisgarh Health Minister TS Singh Deo on Saturday informed he has tested positive for COVID-19. This is the third time the minister, who returned from Delhi on Friday night, has contracted the infection. "After returning from Delhi, I got my COVID-19 test done here in which I tested positive for the coronavirus. Right now I am fine and as per suggestions of doctors, I am complying with the home isolation protocols," Singh Deo tweeted. Earlier, Singh Deo had tested positive in January this year and March last year. As on Friday, Chhattisgarh has a COVID-19 caseload of 11,53,552, including 14,036 deaths, while the active tally is 643.